{"altmetric_id":16017719,"counts":{"readers":{"mendeley":32,"citeulike":0,"connotea":0},"total":{"posts_count":1},"policy":{"unique_users_count":1,"unique_users":["awmf"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4f73cf058f610002fb9","authors":["John D. Durham","Christopher Caputo","John Dokko","Thomas Zaharakis","Mohsen Pahlavan","Jan Keltz","Paula Dutka","Kevin Marzo","John K. Maesaka","Steven Fishbane"],"doi":"10.1046\/j.1523-1755.2002.00673.x","first_seen_on":"2017-02-01T11:01:49+00:00","issns":["00852538"],"journal":"Kidney International","last_mentioned_on":1164844800,"links":["http:\/\/dx.doi.org\/10.1046\/j.1523-1755.2002.00673.x"],"pubdate":"2002-12-01T00:00:00+00:00","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"title":"A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography","type":"article","uri":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815487897","mendeley_url":"http:\/\/www.mendeley.com\/research\/randomized-controlled-trial-nacetylcysteine-prevent-contrast-nephropathy-cardiac-angiography"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":7072054,"mean":6.2889392333429,"rank":1663900,"this_scored_higher_than_pct":64,"this_scored_higher_than":4568140,"rank_type":"exact","sample_size":7072054,"percentile":64},"similar_age_3m":{"total_number_of_other_articles":93666,"mean":11.203462744889,"rank":28638,"this_scored_higher_than_pct":67,"this_scored_higher_than":63471,"rank_type":"exact","sample_size":93666,"percentile":67},"this_journal":{"total_number_of_other_articles":2263,"mean":4.1321282051282,"rank":622,"this_scored_higher_than_pct":55,"this_scored_higher_than":1266,"rank_type":"exact","sample_size":2263,"percentile":55},"similar_age_this_journal_3m":{"total_number_of_other_articles":15,"mean":2.8464285714286,"rank":6,"this_scored_higher_than_pct":60,"this_scored_higher_than":9,"rank_type":"exact","sample_size":15,"percentile":60}}},"demographics":{"users":{"mendeley":{"by_status":{"Professor > Associate Professor":6,"Librarian":1,"Student  > Doctoral Student":3,"Researcher":3,"Student  > Ph. D. Student":1,"Student  > Postgraduate":2,"Student  > Master":5,"Other":7,"Student  > Bachelor":1,"Lecturer":2,"Professor":1},"by_discipline":{"Medicine and Dentistry":25,"Agricultural and Biological Sciences":3,"Computer Science":1,"Unspecified":1,"Pharmacology, Toxicology and Pharmaceutical Science":1,"Arts and Humanities":1}}},"geo":{"mendeley":{"SA":1,"US":2,"GB":1,"AU":1,"PT":1,"EE":1}}},"posts":{"policy":[{"title":"Nationale VersorgungsLeitlinie Typ-2-Diabetes: Pr\u00e4ventions- und Behandlungsstrategien f\u00fcr Fu\u00dfkomplikationen: Langfassung der Leitlinie \"Nationale VersorgungsLeitlinie Typ-2-Diabetes: Pr\u00e4ventions- und Behandlungsstrategien f\u00fcr Fu\u00dfkomplikationen\"","url":"http:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/nvl-001cl_S3_Typ-2-Diabetes_Fusskomplikationen_01.pdf","license":"public","citation_ids":[16017557,15413551,16017558,20534250,3107184,16017561,2114911,16017562,16017564,16017565,16017566,16017567,16017568,16017569,16017570,16017573,16017575,16017577,2113771,16017579,16017580,866545,16017584,16017585,5369271,8518224,16017588,16017591,16017594,16017595,2412362,16017597,16017600,16017601,16017602,16017604,15778375,16068826,16017607,16017608,16017609,9204557,20534275,16017611,4102372,2417977,20534280,16017613,16017614,16017616,20534282,16017619,3682716,16017621,16017624,16017625,16017635,3694218,16017636,16017637,16017638,16017642,16017644,16017646,3686097,16017651,16017655,16017656,20534291,16017658,16017659,16017660,16017662,16017664,16017665,16017668,16017672,1695335,14711923,16017674,2065752,16017679,16017680,16017682,3086607,6235297,16017687,414589,16017690,16017692,16017695,3580257,16017698,20534296,16017700,3197554,16017704,858264,16017705,16017707,16017708,16017710,16017711,16017713,16017716,16017717,16017718,16017719,1484581,16017721,16017722,3242268,16017723,15778617,16017724,16017726,14593893,16017727,16017728,20534302,16017732,16017733,16017734,16017735,16017737,3664634,16017739,15046646,2982821,16017742,16017743,16017744,14859352,16017745,16017746,16017748,16017750,16017751,2417966,5727786,16017755,16017757,16017759,16017762,2369759,20534308,16017764,16017766,16017767,3755736,16017770,16017772,16017774,16017775,870045,1000847,2091224,16017776,2417968,16017778,20534315,16017780,16017781,4792481,16017786,16017789,16195945,16017791,16017792,16017793,20534207,1219633,16017527,1222679,16017530,16017533],"posted_on":"2006-11-30T00:00:00+00:00","source":{"name":"The Association of the Scientific Medical Societies in Germany","description":"The Association of the Scientific Medical Societies in Germany (AWMF) is an umbrella organization of over 150 societies, and advises the government of the Federal Republic of Germany as well as the governments of the German federal countries in all topics of scientific medicine and medical research and classification.","geo":{"country":"DE"}},"page_url":"http:\/\/www.awmf.org\/leitlinien\/detail\/ll\/nvl-001c.html","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-1bd155db22ea922f32055ca744fba9e4057690a0398ef486de47bf805af4ade4.jpg"}}]}}